InvestorsHub Logo
Followers 3
Posts 324
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Wednesday, 07/03/2024 6:21:11 PM

Wednesday, July 03, 2024 6:21:11 PM

Post# of 242
H.C. Wainwright starts Assertio at buy.
The investment bank said it believes Rolvedon could reach peak annual sales of around $140M in the early 2030s. It added that “long run positive traction” from products such as Rolvedon, Otrexup and Sympazan “ought to drive renewed interest from investors.”
The bank set its price target at $4.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASRT News